Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

B.A. Wall, D.A. Galvão, N. Fatehee, D.R. Taaffe, Nigel Spry, David Joseph, R.U. Newton

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    © 2015 Bradley A. Wall et al. Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42-89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. A cross-sectional analysis was undertaken to investigate the potential impact of therapy exposure with participants stratified into two groups according to duration of androgen deprivation therapy (
    Original languageEnglish
    Pages (from-to)1-7
    JournalAdvances in Urology
    Volume2015
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Basal Metabolism
    Implosive Therapy
    Androgens
    Prostatic Neoplasms
    Vascular Stiffness
    Body Composition
    Exercise Test
    Cardiovascular Diseases
    Therapeutics
    Cross-Sectional Studies
    Biomarkers
    Oxygen
    Blood Pressure

    Cite this

    @article{6e079d0be22240e38e6731a08c9045ab,
    title = "Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation",
    abstract = "{\circledC} 2015 Bradley A. Wall et al. Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42-89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. A cross-sectional analysis was undertaken to investigate the potential impact of therapy exposure with participants stratified into two groups according to duration of androgen deprivation therapy (",
    author = "B.A. Wall and D.A. Galv{\~a}o and N. Fatehee and D.R. Taaffe and Nigel Spry and David Joseph and R.U. Newton",
    year = "2015",
    doi = "10.1155/2015/976235",
    language = "English",
    volume = "2015",
    pages = "1--7",
    journal = "Advances in Urology",
    issn = "1687-6369",
    publisher = "Hindawi Publishing Corporation",

    }

    Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation. / Wall, B.A.; Galvão, D.A.; Fatehee, N.; Taaffe, D.R.; Spry, Nigel; Joseph, David; Newton, R.U.

    In: Advances in Urology, Vol. 2015, 2015, p. 1-7.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

    AU - Wall, B.A.

    AU - Galvão, D.A.

    AU - Fatehee, N.

    AU - Taaffe, D.R.

    AU - Spry, Nigel

    AU - Joseph, David

    AU - Newton, R.U.

    PY - 2015

    Y1 - 2015

    N2 - © 2015 Bradley A. Wall et al. Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42-89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. A cross-sectional analysis was undertaken to investigate the potential impact of therapy exposure with participants stratified into two groups according to duration of androgen deprivation therapy (

    AB - © 2015 Bradley A. Wall et al. Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42-89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. A cross-sectional analysis was undertaken to investigate the potential impact of therapy exposure with participants stratified into two groups according to duration of androgen deprivation therapy (

    U2 - 10.1155/2015/976235

    DO - 10.1155/2015/976235

    M3 - Article

    VL - 2015

    SP - 1

    EP - 7

    JO - Advances in Urology

    JF - Advances in Urology

    SN - 1687-6369

    ER -